BioSpace News Archive

Envista Holdings Corporation will report financial results for its fourth quarter 2019 on Thursday, January 30, 2020, after market close

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at the 38th Annual J.P. Morgan Healthcare Conference

IsoPlexis, the leader in single-cell functional proteomics, has announced today that it has raised an additional $20 million in its Series C financing, bringing the entire Series C round to $45 million.

Empirico Inc. announced today that it has entered into a strategic collaboration with Ionis Pharmaceuticals.

Mayo Clinic is creating a library of genomic sequencing data on 100,000 consented Mayo Clinic participants to advance research and patient care.

Mercaptor Discoveries (Mercaptor), a company developing therapeutic agents active exclusively at the site of injury, announced the advancement of its preclinical program in epilepsy.

Study to quantify changes in post-surgical treatment and impact of early relapse detection using Signatera test

Selected from school districts in communities where Northrop Grumman operates across the country, the Teacher Fellows will participate in a variety of science, technology, and engineering-related activities and professional learning opportunities.

Enhancing Drug Development for International Pharma Companies and Chinese Biotechs

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue and adjusted EBITDA estimate for the fourth quarter 2019.